Anal cancer: an overview
HE Uronis, JC Bendell - The Oncologist, 2007 - academic.oup.com
Learning Objectives After completing this course, the reader will be able to: Discuss the
epidemiology of and the risk factors for anal cancer. Outline standard treatment for anal …
epidemiology of and the risk factors for anal cancer. Outline standard treatment for anal …
Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973–2000
LG Johnson, MM Madeleine, LM Newcomer… - Cancer, 2004 - Wiley Online Library
BACKGROUND Anal cancer is a rare malignancy of the anogenital tract that historically has
affected women at a greater rate than men. METHODS The authors analyzed changing …
affected women at a greater rate than men. METHODS The authors analyzed changing …
Cancer in people living with HIV, version 1.2018, NCCN clinical practice guidelines in oncology
E Reid, G Suneja, RF Ambinder, K Ard… - Journal of the National …, 2018 - jnccn.org
People living with HIV (PLWH) are diagnosed with cancer at an increased rate over the
general population and generally have a higher mortality due to delayed diagnoses …
general population and generally have a higher mortality due to delayed diagnoses …
Dose-painted intensity-modulated radiation therapy for anal cancer: a multi-institutional report of acute toxicity and response to therapy
LA Kachnic, HK Tsai, JJ Coen, LS Blaszkowsky… - International Journal of …, 2012 - Elsevier
PURPOSE: Chemoradiation for anal cancer yields effective tumor control, but is associated
with significant acute toxicity. We report our multi-institutional experience using dose-painted …
with significant acute toxicity. We report our multi-institutional experience using dose-painted …
Human immunodeficiency virus/AIDS, human papillomavirus, and anal cancer
JW Chia-ching, J Sparano… - Surgical Oncology …, 2017 - surgonc.theclinics.com
Human papillomavirus (HPV), the most common sexually transmitted infection worldwide,
causes approximately 5% of all cancers in men and 10% of all cancers in women. 1 Anal …
causes approximately 5% of all cancers in men and 10% of all cancers in women. 1 Anal …
HPV-associated anal cancer in the HIV/AIDS patient
CCJ Wang, JM Palefsky - HIV/AIDS-Associated Viral Oncogenesis, 2019 - Springer
The prevalence of anal human papillomavirus (HPV) infection and anal high-grade
squamous intraepithelial lesion (HSIL) remain high among HIV-infected individuals on …
squamous intraepithelial lesion (HSIL) remain high among HIV-infected individuals on …
Human immunodeficiency virus–associated squamous cell cancer of the anus: epidemiology and outcomes in the highly active antiretroviral therapy era
EY Chiao, TP Giordano, P Richardson… - Journal of clinical …, 2008 - ascopubs.org
Purpose To evaluate and determine predictors of squamous cell carcinoma of the anus
(SCCA) outcomes in the highly active antiretroviral therapy (HAART) era for HIV-positive and …
(SCCA) outcomes in the highly active antiretroviral therapy (HAART) era for HIV-positive and …
Invasive anal squamous-cell carcinoma in the HIV-positive patient: outcome in the era of highly active antiretroviral therapy
A Wexler, AM Berson, SE Goldstone… - Diseases of the colon …, 2008 - journals.lww.com
Introduction: The incidence of invasive anal squamous-cell carcinoma in patients with HIV is
increasing. We report the outcome after combined chemoradiotherapy for anal squamous …
increasing. We report the outcome after combined chemoradiotherapy for anal squamous …
Cetuximab plus chemoradiotherapy for HIV-associated anal carcinoma: a phase II AIDS malignancy consortium trial
JA Sparano, JY Lee, J Palefsky, DH Henry… - Journal of Clinical …, 2017 - ascopubs.org
Purpose Squamous cell carcinoma of the anal canal (SCCAC) is characterized by high
locoregional failure (LRF) rates after definitive chemoradiation (CRT), associated with …
locoregional failure (LRF) rates after definitive chemoradiation (CRT), associated with …